BromantaneБромантан
What is it?
A synthetic adamantane-derived compound studied in Russian fatigue and stress research. It belongs to the actoprotector literature and is not a peptide.
Identity / background source ↗
Research context
An actoprotector research entry linked to a small human comparison and an experimental neuropharmacology paper. The findings concern specific settings, not general performance or sleep benefits.
- Working classification
- Actoprotector
- Research collection
- Actoprotection & occupational pharmacology · editorial grouping
- Institutional provenance
- Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —Small comparison
- Study methods
- —10 volunteers + animal work
- Independent replication
- —Not assessed
- Source access
- —English abstracts
- Safety evidence
- —Not assessed
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Linked sources
Explore the research map and unresolved leads ↗
The neuro- and psychophysiological effects of bromantane
O. A. Viatleva, V. G. Barchukov, I. S. Morozov, Iu. A. Salenko, E. N. Zhirnov · Voen Med Zh. 321(8):61–65, 96
The placebo comparison reported EEG and tremor changes, but no change in subjective state or principal operator-performance measures in rested participants.
- Population / setting
- 10 healthy volunteers
- What was checked
- PubMed record and English abstract checked; full paper not reviewed.
Limitations & review scope
- Very small sample and single administration.
- Randomization and allocation details were not established from the abstract.
- The proposed relevance to fatigued operators was not demonstrated by this rested-volunteer comparison.
Source checked 2026-09-27. This is a source-linked record, not a completed evidence review.
The mechanisms of the neurotropic action of bromantan
I. S. Morozov, G. S. Pukhova, N. A. Avdulov, S. A. Sergeeva, A. A. Spasov, I. N. Iezhitsa · Eksp Klin Farmakol. 62(1):11–14
Experimental work examined dopamine, serotonin, and noradrenergic responses. These are mechanistic observations, not evidence of human cognitive or sleep benefits.
- Population / setting
- Animal experiments and synaptosomal assays
- What was checked
- PubMed record and English abstract checked.
Limitations & review scope
- Species, assays, and exposures differ from everyday human use.
- A neurotransmitter-related signal does not establish a clinical mechanism or long-term safety.
Source checked 2026-09-27. This is a source-linked record, not a completed evidence review.
Explore related historical combinations ↗
Browse bibliography & PDFs ↗